Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Klaria Pharma Holding AB (publ) banner
K

Klaria Pharma Holding AB (publ)
STO:KLAR

Watchlist Manager
Klaria Pharma Holding AB (publ)
STO:KLAR
Watchlist
Price: 0.734 SEK -3.42%
Market Cap: kr180.5m
Write Note Create Alert Ask AI

Klaria Pharma Holding AB (publ)
Investor Relations

Klaria Pharma Holding AB engages in the development and commercialization of pharmaceutical products for migraine and cancer-related pain. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2015-10-21. Through its group subsidiaries, the Company is active in developing and commercializing therapeutic drugs and treatment methods in the fields of migraine and pain related to cancer based on a patented drug delivery platform in the form of an alginate-based polymer film, which facilitates rapid and reliable transmucosal absorption via a muco-adhesive film. The firm operates Klaria Pharma AB as a wholly owned subsidiary.

Show more
Loading
KLAR
OMX Stockholm 30
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Scott Boyer
CEO & Director
No Bio Available
Mr. Hans Richter
Chief Financial Officer on Consultative
No Bio Available
Mr. Marc Willuhn Ph.D.
Head of Chemistry, Manufacturing & Control
No Bio Available
Dr. Hans Olivecrona M.D., Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
UPPSALA
Uppsala
Virdings Alle 2
Contacts
+4684464299
www.klaria.com
sparklesyt

See Also

Summary
KLAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
KLAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KLAR stock valuation using valuation multiples.
Wall Street Estimates
KLAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KLAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 320,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.